Xenon Pharmaceuticals(XENE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

XENE Xenon Pharmaceuticals

Market Closed 05-29 16:00:00 EDT

54.73

-0.06

-0.11%

盘后54.73

+0.000.00%

17:40 EDT

High55.39	Low54.37	Vol1.38M
Open54.76	D1 Closing54.79	Amplitude1.85%
Mkt Cap5.29B	Tradable Cap4.92B	Total Shares96.64M
T/O75.30M	T/O Rate1.53%	Tradable Shares89.89M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"XENE","market":"US","secType":"STK","nameCN":"Xenon Pharmaceuticals","latestPrice":54.73,"timestamp":1780084800000,"preClose":54.79,"halted":0,"volume":1375299,"hourTrading":{"tag":"盘后","latestPrice":54.73,"preClose":54.73,"latestTime":"17:40 EDT","volume":44780,"amount":2450797.435,"timestamp":1780090856198,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0010950903449535002,"floatShares":89889500,"shares":96642822,"eps":-4.706128,"marketStatus":"Market Closed","change":-0.06,"latestTime":"05-29 16:00:00 EDT","open":54.76,"high":55.385,"low":54.37,"amount":75304551.75696,"amplitude":0.018525,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.706128,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1415163600000,"exchange":"NASDAQ","adjPreClose":54.79,"preHourTrading":{"tag":"盘前","latestPrice":55.06,"preClose":54.79,"latestTime":"09:16 EDT","volume":57,"amount":3146.330004,"timestamp":1780060586183,"change":0.27,"changeRate":0.004928,"amplitude":0.022084},"postHourTrading":{"tag":"盘后","latestPrice":54.73,"preClose":54.73,"latestTime":"17:40 EDT","volume":44780,"amount":2450797.435,"timestamp":1780090856198,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7950512203152296,"impliedVol":0.4107,"impliedVolPercentile":0.2988},"requestUrl":"/m/hq/s/XENE","defaultTab":"news","newsList":[{"id":"2639672437","title":"BRIEF-Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672437","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672437?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:01","pubTimestamp":1780084918,"startTime":"0","endTime":"0","summary":"BRIEF-Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing RuleMay 29 (Reuters) - Xenon Pharmaceuticals Inc XENE.O:XENON PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUABYY4TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XENE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639672453","title":"Xenon Pharma grants 32,750 inducement stock options priced at $54.79 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672453","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672453?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:01","pubTimestamp":1780084881,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals granted equity inducement awards to 10 new non-officer employees, totaling 32,750 share options, 19,200 RSUs.Options carry a $54.79 exercise price, matching the May 28, 2026 close; each option has a 10-year term.Options vest over four years: 25% after year one, then monthly for the remaining 36 months, subject to continued service.RSUs vest 25% on each of the first four anniversaries of the employee’s start date, subject to continued service.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDLbBf0HT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","XENE","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","BK4112","SG9999014005.SGD","BK4139","LU2210150020.SGD","SG9999014039.USD","LU0314104364.USD","BK4585","SG9999014021.USD","BK4588","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","SG9999014013.SGD","IE00BKPKM429.USD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639672176","title":"Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672176?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:01","pubTimestamp":1780084860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUABYY4TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XENE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638686808","title":"Xenon Pharmaceuticals Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2638686808","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638686808?lang=en_us&edition=fundamental","pubTime":"2026-05-27 22:01","pubTimestamp":1779890460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XENE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2026 10:01 ET (14:01 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638688575","title":"Xenon Pharmaceuticals price target raised to $82 from $80 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2638688575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638688575?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:35","pubTimestamp":1779885312,"startTime":"0","endTime":"0","summary":"JPMorgan raised the firm’s price target on Xenon Pharmaceuticals (XENE) to $82 from $80 and keeps a Neutral rating on the shares. The firm updated ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-price-target-raised-to-82-from-80-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-price-target-raised-to-82-from-80-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636281833","title":"Xenon Pharmaceuticals Signals Strong Momentum In Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2636281833","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636281833?lang=en_us&edition=fundamental","pubTime":"2026-05-20 13:05","pubTimestamp":1779253557,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals (($XENE)) has held its Q1 earnings call. Read on for the main highlights of the call. Xenon Pharmaceuticals’ latest earnings ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xenon-pharmaceuticals-signals-strong-momentum-in-earnings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xenon-pharmaceuticals-signals-strong-momentum-in-earnings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635379964","title":"A Look At Xenon Pharmaceuticals (XENE) Valuation After Phase III Azetukalner Milestones And Extended Cash Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2635379964","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635379964?lang=en_us&edition=fundamental","pubTime":"2026-05-14 14:50","pubTimestamp":1778741421,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals (XENE) stock is in focus after the company paired encouraging Phase III azetukalner epilepsy data with plans for a Q3 2026 NDA filing and a defined commercial launch timeline.\nSee our latest analysis for Xenon Pharmaceuticals.\nDespite a softer 7 day and 30 day share price return, Xenon’s recent Phase III update and extended cash runway have come after a 34.26% 90 day share price return and a very strong 1 year total shareholder return of 87.9%. This suggests that...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xene/xenon-pharmaceuticals/news/a-look-at-xenon-pharmaceuticals-xene-valuation-after-phase-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xene/xenon-pharmaceuticals/news/a-look-at-xenon-pharmaceuticals-xene-valuation-after-phase-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4134","XENE","III","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634106243","title":"Xenon Pharmaceuticals Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2634106243","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634106243?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:23","pubTimestamp":1778599380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XENE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 12, 2026 11:23 ET (15:23 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634404219","title":"Xenon Pharmaceuticals price target raised to $80 from $77 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2634404219","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634404219?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:13","pubTimestamp":1778588036,"startTime":"0","endTime":"0","summary":"JPMorgan analyst Tessa Romero raised the firm’s price target on Xenon Pharmaceuticals (XENE) to $80 from $77 and keeps an Overweight rating on the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-price-target-raised-to-80-from-77-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-price-target-raised-to-80-from-77-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634475369","title":"Xenon (XENE) Gets a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2634475369","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634475369?lang=en_us&edition=fundamental","pubTime":"2026-05-11 10:40","pubTimestamp":1778467236,"startTime":"0","endTime":"0","summary":"In a report released on May 8, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Xenon, with a price target of $86.00. The company’s sha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/xenon-xene-gets-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/xenon-xene-gets-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XENE","BK4127","BK4139","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634428805","title":"Xenon Pharmaceuticals price target raised to $69 from $68 at Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2634428805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634428805?lang=en_us&edition=fundamental","pubTime":"2026-05-10 22:21","pubTimestamp":1778422888,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Benjamin Burnett raised the firm’s price target on Xenon Pharmaceuticals (XENE) to $69 from $68 and keeps an Overweight rating ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-price-target-raised-to-69-from-68-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-price-target-raised-to-69-from-68-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634966440","title":"Wells Fargo Remains a Buy on Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634966440","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634966440?lang=en_us&edition=fundamental","pubTime":"2026-05-10 21:40","pubTimestamp":1778420417,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Benjamin Burnett maintained a Buy rating on Xenon on May 8 and set a price target of $69.00. The company’s shares closed last F...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-remains-a-buy-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-remains-a-buy-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0251142724.SGD","BK4585","IE00B7SZLL34.SGD","LU0417517546.SGD","LU0175139822.USD","LU1267930490.SGD","BK4582","LU0211328371.USD","LU1894683348.USD","LU0128525929.USD","LU0128525689.USD","LU1267930573.SGD","LU1069347547.HKD","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0289960550.SGD","LU1267930227.SGD","LU2236285917.USD","LU0048573561.USD","LU1506573853.SGD","LU0787776722.HKD","LU0648001328.SGD","LU0980610538.SGD","XENE","LU1668664300.SGD","LU0683600562.USD","LU1814569148.SGD","PGF","BK4559","LU0310800965.SGD","LU0070302665.USD","LU0314106906.USD","LU0640476718.USD","LU1074936037.SGD","LU0310800379.SGD","LU0106831901.USD","LU0154236417.USD","LU2361045086.USD","LU0477156953.USD","LU0868494708.USD","BK4207","LU1035773651.USD","LU1363072403.SGD","LU0742534661.SGD","LU0072461881.USD","LU0971096721.USD","LU2361044949.HKD","BK4504","LU0130102774.USD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634849830","title":"Xenon Pharmaceuticals price target lowered to $78 from $80 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2634849830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634849830?lang=en_us&edition=fundamental","pubTime":"2026-05-09 06:33","pubTimestamp":1778279604,"startTime":"0","endTime":"0","summary":"Needham analyst Serge Belanger lowered the firm’s price target on Xenon Pharmaceuticals (XENE) to $78 from $80 and keeps a Buy rating on the shares...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-price-target-lowered-to-78-from-80-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xenon-pharmaceuticals-price-target-lowered-to-78-from-80-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453003","title":"Xenon Pharmaceuticals Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453003?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:46","pubTimestamp":1778240760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XENE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 08, 2026 07:46 ET (11:46 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633532344","title":"Needham Reaffirms Their Buy Rating on Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633532344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633532344?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:35","pubTimestamp":1778240134,"startTime":"0","endTime":"0","summary":"Needham analyst Serge Belanger maintained a Buy rating on Xenon today and set a price target of $78.00. According to TipRanks, Belanger is a 5-star...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/needham-reaffirms-their-buy-rating-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/needham-reaffirms-their-buy-rating-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633194430","title":"H.C. Wainwright Remains a Buy on Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633194430","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633194430?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:55","pubTimestamp":1778237748,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Xenon today and set a price target of $74.00. Tsao covers the Healthcare sector, fo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4588","BK4585","XENE","LABU","BK4139","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633865108","title":"Xenon Pharmaceuticals Q1 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2633865108","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633865108?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:28","pubTimestamp":1778189283,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals (XENE) reported late Thursday a Q1 net loss of $1.17 per diluted share, compared with a loss of $0.83 a year earlier.Based on current operating plans, Xenon said it expects having sufficient cash to fund operations into 2029.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XENE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633332170","title":"Earnings Flash (XENE) Xenon Pharmaceuticals Posts Q1 Per Share Loss $1.17, vs. FactSet Est of Loss $1.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2633332170","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633332170?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:05","pubTimestamp":1778187923,"startTime":"0","endTime":"0","summary":"Earnings Flash (XENE) Xenon Pharmaceuticals Posts Q1 Per Share Loss $1.17, vs. FactSet Est of Loss $1.18","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633779031","title":"Xenon Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633779031","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633779031?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:01","pubTimestamp":1778187681,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings SummaryXenon Pharmaceuticals Inc XENE.OQ reported a quarterly adjusted loss of $1.17 per share for the quarter ended","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K3A4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XENE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633135179","title":"Canada's Xenon reports Q1 net loss slightly better than expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2633135179","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633135179?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:11","pubTimestamp":1778184708,"startTime":"0","endTime":"0","summary":"Canada's Xenon reports Q1 net loss slightly better than expectedOverviewCanada neuroscience drug developer's Q1 net loss and EPS slightly beat analyst expectationsQ1 revenue fell to zero from $7.5 mln","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL1N41K1J0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XENE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xenon-pharma.com;investor.xenon-pharma.com","stockEarnings":[{"period":"1week","weight":0.0103},{"period":"1month","weight":-0.0183},{"period":"3month","weight":0.266},{"period":"6month","weight":0.2238},{"period":"1year","weight":0.8846},{"period":"ytd","weight":0.2211}],"compareEarnings":[{"period":"1week","weight":0.0145},{"period":"1month","weight":0.0631},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.107},{"period":"1year","weight":0.2821},{"period":"ytd","weight":0.1093}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, a Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epileptic encephalopathy; and XEN1101, a Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.008322},{"month":2,"riseRate":0.75,"avgChangeRate":0.076063},{"month":3,"riseRate":0.25,"avgChangeRate":-0.040327},{"month":4,"riseRate":0.5,"avgChangeRate":0.017963},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.036246},{"month":6,"riseRate":0.454545,"avgChangeRate":0.032291},{"month":7,"riseRate":0.363636,"avgChangeRate":0.01913},{"month":8,"riseRate":0.727273,"avgChangeRate":0.07504},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.05886},{"month":10,"riseRate":0.454545,"avgChangeRate":0.054946},{"month":11,"riseRate":0.727273,"avgChangeRate":0.050412},{"month":12,"riseRate":0.666667,"avgChangeRate":0.089745}],"exchange":"NASDAQ","name":"Xenon Pharmaceuticals","nameEN":"Xenon Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xenon Pharmaceuticals(XENE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Xenon Pharmaceuticals(XENE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Xenon Pharmaceuticals,XENE,Xenon Pharmaceuticals股票,Xenon Pharmaceuticals股票老虎,Xenon Pharmaceuticals股票老虎国际,Xenon Pharmaceuticals行情,Xenon Pharmaceuticals股票行情,Xenon Pharmaceuticals股价,Xenon Pharmaceuticals股市,Xenon Pharmaceuticals股票价格,Xenon Pharmaceuticals股票交易,Xenon Pharmaceuticals股票购买,Xenon Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xenon Pharmaceuticals(XENE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Xenon Pharmaceuticals(XENE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}